BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Enliven Therapeutics
ELVN
$4.43B
| $63.8M | ﹤0.01% |
2,730,773
+917,422
| +51% | +$19.3M |
|
2277
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
| $63.6M | ﹤0.01% |
291,683
+69,138
| +31% | +$15.2M |
|
2278
Mercantile Bank Corp
MBWM
$1.05B
| $63.4M | ﹤0.01% |
1,562,417
+59,132
| +4% | +$2.21M |
|
2279
Forestar Group
FOR
$1.51B
| $63.2M | ﹤0.01% |
1,976,512
-14,641
| -0.7% | -$495K |
|
2280
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
| $63M | ﹤0.01% |
1,420,854
+1,396,661
| +5,773% | +$61.6M |
|
2281
Perella Weinberg Partners
PWP
$1.3B
| $62.9M | ﹤0.01% |
3,870,887
+556,965
| +17% | +$8.41M |
|
2282
Travere Therapeutics
TVTX
$5.78B
| $62.8M | ﹤0.01% |
7,644,789
-151,977
| -2% | -$1.02M |
|
2283
iShares MSCI France ETF
EWQ
$345M
| $62.5M | ﹤0.01% |
1,654,060
-412,915
| -20% | -$16.8M |
|
|
DAWN
2284
DELISTED
Day One Biopharmaceuticals
DAWN
| $62.5M | ﹤0.01% |
4,533,442
-497,993
| -10% | -$7.29M |
|
2285
Seaboard Corp
SEB
$4.06B
| $62.4M | ﹤0.01% |
19,753
+2,370
| +14% | +$7.63M |
|
2286
CG Oncology
CGON
$6.66B
| $62.4M | ﹤0.01% |
1,976,070
-542,480
| -22% | -$18.8M |
|
2287
Viridian Therapeutics
VRDN
$2.67B
| $62.1M | ﹤0.01% |
4,773,622
+960,992
| +25% | +$13.3M |
|
2288
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.03B
| $62M | ﹤0.01% |
919,771
-2,285
| -0.2% | -$154K |
|
2289
Canadian Natural Resources
CNQ
$93.8B
| $62M | ﹤0.01% |
1,741,442
-70,994
| -4% | -$2.67M |
|
2290
Arhaus
ARHS
$1.36B
| $61.9M | ﹤0.01% |
3,655,769
+2,523,878
| +223% | +$40.9M |
|
2291
Cullinan Oncology
CGEM
$1.14B
| $61.9M | ﹤0.01% |
3,550,207
+1,121,214
| +46% | +$23.9M |
|
2292
Shinhan Financial Group
SHG
$35.6B
| $61.8M | ﹤0.01% |
1,775,156
-86,059
| -5% | -$2.89M |
|
2293
Summit Therapeutics
SMMT
$11.1B
| $61.6M | ﹤0.01% |
7,898,585
-1,924,756
| -20% | -$10.4M |
|
2294
CALL
Boston Scientific
BSX
$71.5B
| $61.6M | ﹤0.01% |
+800,000
| New | +$58.6M |
|
2295
Cogent Biosciences
COGT
$7.24B
| $61.4M | ﹤0.01% |
7,288,378
+598,760
| +9% | +$4.54M |
|
2296
Janus Henderson AAA CLO ETF
JAAA
$29.2B
| $61.4M | ﹤0.01% |
1,206,962
+1,102,469
| +1,055% | +$55.9M |
|
2297
Movado Group
MOV
$841M
| $61.3M | ﹤0.01% |
2,466,311
-69,318
| -3% | -$1.81M |
|
|
CVGW
2298
DELISTED
Calavo Growers
CVGW
| $61.2M | ﹤0.01% |
2,697,003
-135,077
| -5% | -$3.54M |
|
2299
Mobileye
MBLY
$2.2B
| $61.1M | ﹤0.01% |
2,174,741
+384,664
| +21% | +$11.1M |
|
2300
First Mid Bancshares
FMBH
$1.36B
| $60.8M | ﹤0.01% |
1,848,870
+62,030
| +3% | +$1.95M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,440 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.